Our latest news, insights & events
Our team reviewed the landscape in Israel regarding Environmental, Social and Governance Law in 2021. The team, Janet Pahima, Liat
Proud to contribute again to a Global Legal Group’s International Comparative Legal Guide
Happy to update that the Israeli Supreme Court rejected an application for an order to suspend an important tender of
The Supreme Court rejected an application to suspend a tender for our client Solel Boneh
Our Client, TelCann LTD, a licensed medical cannabis cultivator, has signed a substantial agreement with Canonic, a company focused on
Our Client TelCann LTD, has signed a substantial agreement with Canonic.
We are excited to share with you that Chile Ezra, a Hungarian woman who was taken to Israel by human
Partner Hen Tirosh represented Chile Ezra in a complicated Pro Bono case
We are proud to have represented Unity, the world’s leading platform for creating and operating real-time 3D content for a
Our client Unity recently acquired RestAR
This week, it was published that the US Federal Trade Commission and some of the American states are preparing antitrust
Killer Acquisitions and Exit Strategies
Our clients, venture capital fund Behrens Investment Group, were the leading investors in the Series B financing round of Israeli business
Our clients Behrens Investment Group, were the leading investors in the financing round of Israeli startup Intelligo Group.
We were excited to work with Percepto – Autonomous Drones on its latest financing round, in which Percepto raise approximately $45 million
Our clients Percepto raised approximately $45 million in consideration for Series B Preferred Stock.
The hack and data stolen from the insurance company Shirbit reminded Israelis of the potential damage of such an event.
Partner Nimrod Kozlovski interview to 103fm
Our client, Israeli open-source company Logz.io raised $23 million in a Series E round led by Pitango Growth. The company develops an open-source platform
Our client Logz.io raised $23 million in a Series E round
What happens when a doctor thinks it is necessary to recommend an Off-Label use of a drug? What if that
